Search Results - "Arienti, Flavio"
-
1
Alternative Activation of Human Plasmacytoid DCs In Vitro and in Melanoma Lesions: Involvement of LAG-3
Published in Journal of investigative dermatology (01-07-2014)“…Plasmacytoid dendritic cells (pDCs) at tumor sites are often tolerogenic. Although pDCs initiate innate and adaptive immunity upon Toll-like receptor (TLR)…”
Get full text
Journal Article -
2
Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesis
Published in Journal for immunotherapy of cancer (12-10-2024)“…Colorectal cancer (CRC) remains a significant healthcare burden worldwide, characterized by a complex interplay between obesity and chronic inflammation. While…”
Get full text
Journal Article -
3
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients
Published in Journal for immunotherapy of cancer (01-02-2021)“…BackgroundMyeloid-derived suppressor cells (MDSC), a cornerstone of cancer-related immunosuppression, influence response to therapy and disease outcomes in…”
Get full text
Journal Article -
4
Detection of mutated BRAFV600E variant in circulating DNA of stage III–IV melanoma patients
Published in International journal of cancer (01-06-2007)“…BRAFV600E is the most represented somatic point mutation in cutaneous melanoma, thus providing a unique molecular marker for this disease. The development of…”
Get full text
Journal Article -
5
Impaired STAT Phosphorylation in T Cells from Melanoma Patients in Response to IL-2: Association with Clinical Stage
Published in Clinical cancer research (15-06-2009)“…Purpose: To assess the extent of signal transducer and activator of transcription (STAT) activation in response to interleukin 2 (IL-2) in melanoma patients' T…”
Get full text
Journal Article -
6
Induction of Both CD8+ and CD4+ T-Cell–Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1
Published in Clinical cancer research (15-11-2008)“…Purpose: Colon antigen-1 (COA-1) was recently identified as a novel antigen of colorectal cancer encoded by the UBXD5 gene. Here, we evaluated whether a…”
Get full text
Journal Article -
7
Identification of the novel HLA‐C allele, HLA‐C04:520
Published in HLA (01-06-2024)“…HLA‐C*04:520, a novel HLA‐C allele, differs from HLA‐C*04:01:01 by one mismatch in exon 5…”
Get full text
Journal Article -
8
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
Published in The Journal of clinical investigation (01-12-2018)“…The accrual of myeloid-derived suppressor cells (MDSCs) represents a major obstacle to effective immunotherapy in cancer patients, but the mechanisms…”
Get full text
Journal Article -
9
Shear-Induced Encapsulation into Red Blood Cells: A New Microfluidic Approach to Drug Delivery
Published in Annals of biomedical engineering (2020)“…Encapsulating molecules into red blood cells (RBCs) is a challenging topic for drug delivery in clinical practice, allowing to prolong the residence time in…”
Get full text
Journal Article -
10
A Microsatellite in the Coding Sequence of HLA-A/B Is a Mutation Hotspot in Colon Cancer With Microsatellite Instability
Published in Gastroenterology (New York, N.Y. 1943) (01-03-2022)Get full text
Journal Article -
11
113 Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancers (NPC)
Published in Radiotherapy and oncology (01-03-2024)“…Plasma Epstein Barr virus (EBV)-DNA is employed as a biomarker for EBER (EBV-encoded RNA) positive nasopharyngeal cancer (NPC) patients. In Europe, the use of…”
Get full text
Journal Article -
12
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
Published in Oncotarget (26-01-2016)“…In melanoma, the adaptative cell response to BRAF inhibitors includes altered patterns of cytokine production contributing to tumor progression and drug…”
Get full text
Journal Article -
13
The Real Life Accessibility to CAR T-Cell Therapy: Current Experience in the Only Active Center in Italy
Published in Blood (13-11-2019)“…BACKGROUND. Axicabtagene ciloleucel and tisagenlecleucel have been approved by FDA and EMA for the treatment of relapsed/refractory diffuse large B-cell and…”
Get full text
Journal Article -
14
A Supportive Care in Cancer Unit Reduces Costs and Hospitalizations for Transfusions in a Comprehensive Cancer Center
Published in Tumori (01-09-2017)“…Purpose Among patients with solid or hematologic malignancies undergoing oncologic therapies, blood product transfusions (BPT) are a relevant reason for…”
Get full text
Journal Article -
15
Preclinical pharmacology of patient-derived extracellular vesicles for the intraoperative imaging of tumors
Published in Theranostics (2024)“…Extracellular vesicles (EVs) derived from the plasma of oncological patients exhibit significant tumor-targeting properties, unlike those from healthy…”
Get full text
Journal Article -
16
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment
Published in Journal of investigative dermatology (01-02-2017)“…Dermatofibrosarcoma protuberans (DFSP), although rare, is the most frequent skin sarcoma. Here, we focus on DFSP carrying the fibrosarcomatous transformation…”
Get full text
Journal Article -
17
Application of Controlled Shear Stresses on the Erythrocyte Membrane as a New Approach to Promote Molecule Encapsulation
Published in Artificial organs (01-10-2016)“…Human red blood cells (RBCs) have a remarkable capacity to undergo reversible membrane swelling. Resealed erythrocytes have been proposed as carriers and…”
Get full text
Journal Article -
18
Monocytes in leukapheresis products affect the outcome of CD19–targeted CAR T-cell therapy in patients with lymphoma
Published in Blood advances (23-04-2024)“…•Combining circulating absolute monocyte count and a 4-gene monocyte signature at leukapheresis predicts PFS of LBCL receiving CAR T cells.•Monocytes depletion…”
Get full text
Journal Article -
19
Epidural analgesia for cytoreductive surgery with peritonectomy and heated intraperitoneal chemotherapy
Published in International journal of surgery (London, England) (01-04-2015)“…Abstract Purpose To evaluate epidural analgesia role after cytoreductive surgery with peritonectomy combined with heated intraperitoneal chemotherapy. Methods…”
Get full text
Journal Article -
20
Tumor-Reactive CD8+ Early Effector T Cells Identified at Tumor Site in Primary and Metastatic Melanoma
Published in Cancer research (Chicago, Ill.) (01-11-2010)“…CD8(+) T cells at the earliest stage of effector generation have not been identified at tumor site of melanoma patients. Such early effectors, if present,…”
Get full text
Journal Article